IUPS Physiome Project
  • Models Home
  • Exposures
  • Documentation
  • Log in
You are here: Home / Exposures / Bonhoeffer, Rembiszewski, Ortiz, Nixon, 2000 / Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection: Model 2
Info

Generated Code

  • C
  • C_IDA
  • F77
  • MATLAB
  • Python
Source
Derived from workspace Bonhoeffer, Rembiszewski, Ortiz, Nixon, 2000 at changeset 5c47e500d24a.
Collaboration
To begin collaborating on this work, please use your git client and issue this command:
Downloads
  • Download This File
  • Complete Archive as .tgz
  • COMBINE Archive (exposure)
Views Available
  • Documentation
  • Model Metadata
  • Mathematics
  • Generated Code
  • Cite this model
  • Source View
  • Semantic Metadata
  • Launch with OpenCOR
Tools
  • Compare...
  • Export Exposure Metadata
  • CombineArchive Web
License

This work is licensed under a Creative Commons Attribution 3.0 Unported License.

Navigation
  • Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection: Model 1
  • Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection: Model 2
  • Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection: Model 3
© 2001-2022 - The CellML Project.
  • Site Map
  • Accessibility
  • Contact
  • About